The global community continues to grapple with the effects of COVID-19. This is certainly true for the United States, where the virus has impacted not only healthcare but the economy at large. As a result, covered lives in the U.S. are shifting in a profound way.
Life science companies are now tasked with understanding how these substantial shifts in lives enrollment affect their strategic positioning at both national and regional levels, as well as the implications for the commercial, Medicare, and Medicaid segments. They are not only interested in the present state, but how to confidently measure the months and years ahead.
Decision Resources Group is pleased to provide this high-level view on the national and regional trends within the U.S. market as a result of COVID-19.
Top covered include:
- Enrollment shift projected at national level
- Changes within the commercial market
- 2021 commercial premium rates
- Impact on ACA related coverage
- Prescription drug benefits
- Regional impact and trends
- Medicare impact and trends
- Medicaid impact and trends
